IMMUNOLOGY AND IMMUNE BASED THERAPY AGENDA
IMMUNOLOGY AND IMMUNE BASED THERAPY AGENDA
批准号:
6099225
负责人:
John P Phair
金额:
$20.66万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 1999-12-31
关键词:
AIDS AIDS related neoplasm /cancer AIDS therapy HIV infections antineoplastics biomarker cellular immunity clinical research communicable disease control cooperative study cytokine human immunodeficiency virus 1 human subject human therapy evaluation humoral immunity immunization immunomodulators immunotherapy neoplasm /cancer immunotherapy opportunistic infections oxidative stress pathologic process virus load virus replication
中文摘要
点击翻译按钮获取中文摘要
英文摘要
OBJECTIVES: The objectives of this study are to assess PMNL function in
HIV+ patients at different stages of disease over an extended period of
time, determine if abnormal PMNL function predisposes patients to bacterial
infections, and examine the various factors that may affect PMNL function.
In addition, we will examine whether or not defects in PMNL function can be
reversed by in vitro exposure to colony-stimulating factors.
METHODS: Subjects. HIV-infected patients will be grouped according to
CD4+ counts (> 500/mm3, 200-500/mm3, and < 200/mm3) and whether or not they
are receiving anti-retroviral therapy. Controls groups will consist of
patients at risk for HIV infection with a negative HIV antibody test and
healthy volunteers without risk factor for HIV infection. Clinical data,
including age, risk factors for HIV infection, staging (CDC, Walter Reed),
and the occurrence of bacterial infections will be recorded.
PMNL function. PMNLs will be isolated from patients and controls and a
battery of function assays performed. Chemotaxis, adherence, aggregation,
superoxide production in response to stimuli (f-met-leu-phe, PMA, and
opsonized zymosan) in a superoxide dismutase (SOD) inhibitable cytochrome C
reduction microassay, phagocytosis, and bacterial killing will be
determined for patients and compared to the paired control.
Effect of colony-stimulating factors on PMNL function. PMNLs will be
preincubated with granulocyte and granulocyte-macrophage colony-stimulating
factors (G-CSF, GM-CSF) and tested with the battery of assays described
above.
Factors associated with abnormal PMNL function. We plan to measure
circulating levels of immunoglobulins, fibronectin, PMNL chemoattractants
(C5a, leukotriene B4, and platelet activating factor), cytokines that
affect PMNL function (TNF, IL-1, and gamma-interferon), and colony-
stimulating factors, and correlate levels with PMNL function.
Fluorocytometry will be used to detect anti-neutrophil antibodies and the
expression of PMNL surface markers that are associated with normal PMNL
function.
Methods of Analysis. The results of PMNL function tests will be reported
as the mean plus/minus standard deviation. The means of groups will be
analyzed by the Student's test and ANOVA. The relationship between stage
of disease and PMNL function will be analyzed by linear regression and
ANOVA. Associations between bacterial infections and PMNL function, anti-
retroviral therapy, circulating factors, anti-retroviral therapy,
circulating factors, anti-PMNL antibodies, surface markers, and other
parameters will be analyzed by multivariate analysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multicenter AIDS Cohort Study
-
批准号:8138167
-
项目类别:
-
资助金额:$598.5万
-
财政年份:2010
-
负责人:John P Phair
-
依托单位:
Multicenter AIDS Cohort Study
-
批准号:8119192
-
项目类别:
-
资助金额:$148.69万
-
财政年份:2010
-
负责人:John P Phair
-
依托单位:
Multicenter AIDS Cohort Study
-
批准号:7926213
-
项目类别:
-
资助金额:$3.39万
-
财政年份:2009
-
负责人:John P Phair
-
依托单位:
CORE--CLINICAL RESEARCH
-
批准号:6346050
-
项目类别:
-
资助金额:$17.33万
-
财政年份:2000
-
负责人:John P Phair
-
依托单位:
OUTREACH AGENDA
-
批准号:6099229
-
项目类别:
-
资助金额:$20.66万
-
财政年份:1999
-
负责人:John P Phair
-
依托单位:
HIV DISEASE RESEARCH AGENDA
-
批准号:6099222
-
项目类别:
-
资助金额:$20.66万
-
财政年份:1999
-
负责人:John P Phair
-
依托单位:
CORE--CLINICAL RESEARCH
-
批准号:6203475
-
项目类别:
-
资助金额:$17.33万
-
财政年份:1999
-
负责人:John P Phair
-
依托单位:
COMPLICATIONS OF HIV DISEASE AGENDA
-
批准号:6099223
-
项目类别:
-
资助金额:$20.66万
-
财政年份:1999
-
负责人:John P Phair
-
依托单位:
NEUROLOGY AGENDA
-
批准号:6099224
-
项目类别:
-
资助金额:$20.66万
-
财政年份:1999
-
负责人:John P Phair
-
依托单位:
PHARMACOLOGY AGENDA
-
批准号:6099226
-
项目类别:
-
资助金额:$20.66万
-
财政年份:1999
-
负责人:John P Phair
-
依托单位:
WOMEN'S HEALTH AGENDA
-
批准号:6099227
-
项目类别:
-
资助金额:$20.66万
-
财政年份:1999
-
负责人:John P Phair
-
依托单位:
CORE--ADVANCED TECHNOLOGY LABORATORIES
-
批准号:6099230
-
项目类别:
-
资助金额:$20.66万
-
财政年份:1999
-
负责人:John P Phair
-
依托单位:
OUTCOMES COMMITTEE AGENDA
-
批准号:6099228
-
项目类别:
-
资助金额:$20.66万
-
财政年份:1999
-
负责人:John P Phair
-
依托单位:
COMPLICATIONS OF HIV DISEASE AGENDA
-
批准号:6267849
-
项目类别:
-
资助金额:$19.93万
-
财政年份:1998
-
负责人:John P Phair
-
依托单位:
OUTREACH AGENDA
-
批准号:6267855
-
项目类别:
-
资助金额:$19.93万
-
财政年份:1998
-
负责人:John P Phair
-
依托单位:
WOMEN'S HEALTH AGENDA
-
批准号:6267853
-
项目类别:
-
资助金额:$19.93万
-
财政年份:1998
-
负责人:John P Phair
-
依托单位:
PHARMACOLOGY AGENDA
-
批准号:6267852
-
项目类别:
-
资助金额:$19.93万
-
财政年份:1998
-
负责人:John P Phair
-
依托单位:
CORE--ADVANCED TECHNOLOGY LABORATORIES
-
批准号:6267856
-
项目类别:
-
资助金额:$19.93万
-
财政年份:1998
-
负责人:John P Phair
-
依托单位:
OUTCOMES COMMITTEE AGENDA
-
批准号:6267854
-
项目类别:
-
资助金额:$19.93万
-
财政年份:1998
-
负责人:John P Phair
-
依托单位:
CORE--CLINICAL RESEARCH
-
批准号:6103528
-
项目类别:
-
资助金额:$17.33万
-
财政年份:1998
-
负责人:John P Phair
-
依托单位: